Evusheld

Evusheld is a long-acting investigational protective measure against COVID-19, featuring a combination of two monoclonal antibodies. The FDA recently gave its approval under an emergency use authorization (EUA). Evusheld is a game-changer for liver patients and other individuals with a compromised immune system. What is Evusheld, and Who Can Use It? Evusheld is a combination […]